Cargando…

New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination

Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syndrome. We herein report a case of new-onset Evans syndrome associated with SLE after BNT162...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidaka, Daisuke, Ogasawara, Reiki, Sugimura, Shunsuke, Fujii, Fumiaki, Kojima, Keisuke, Nagai, Jun, Ebata, Ko, Okada, Kohei, Kobayashi, Naoki, Ogasawara, Masahiro, Imamura, Masahiro, Ota, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536917/
https://www.ncbi.nlm.nih.gov/pubmed/34687421
http://dx.doi.org/10.1007/s12185-021-03243-2
_version_ 1784588125216964608
author Hidaka, Daisuke
Ogasawara, Reiki
Sugimura, Shunsuke
Fujii, Fumiaki
Kojima, Keisuke
Nagai, Jun
Ebata, Ko
Okada, Kohei
Kobayashi, Naoki
Ogasawara, Masahiro
Imamura, Masahiro
Ota, Shuichi
author_facet Hidaka, Daisuke
Ogasawara, Reiki
Sugimura, Shunsuke
Fujii, Fumiaki
Kojima, Keisuke
Nagai, Jun
Ebata, Ko
Okada, Kohei
Kobayashi, Naoki
Ogasawara, Masahiro
Imamura, Masahiro
Ota, Shuichi
author_sort Hidaka, Daisuke
collection PubMed
description Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syndrome. We herein report a case of new-onset Evans syndrome associated with SLE after BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccination in a 53-year-old woman. Blood examination at diagnosis showed hemolytic anemia with a positive Coombs test and thrombocytopenia. Hypocomplementemia and the presence of lupus anticoagulant indicated a strong association with SLE. Prednisolone administration rapidly restored hemoglobin level and platelet count. This case suggests that mRNA COVID-19 vaccination may cause an autoimmune disorder. Physicians should be aware of this adverse reaction by mRNA COVID-19 vaccination and should consider the benefits and risks of vaccination for each recipient.
format Online
Article
Text
id pubmed-8536917
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-85369172021-10-25 New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination Hidaka, Daisuke Ogasawara, Reiki Sugimura, Shunsuke Fujii, Fumiaki Kojima, Keisuke Nagai, Jun Ebata, Ko Okada, Kohei Kobayashi, Naoki Ogasawara, Masahiro Imamura, Masahiro Ota, Shuichi Int J Hematol Case Report Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syndrome. We herein report a case of new-onset Evans syndrome associated with SLE after BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccination in a 53-year-old woman. Blood examination at diagnosis showed hemolytic anemia with a positive Coombs test and thrombocytopenia. Hypocomplementemia and the presence of lupus anticoagulant indicated a strong association with SLE. Prednisolone administration rapidly restored hemoglobin level and platelet count. This case suggests that mRNA COVID-19 vaccination may cause an autoimmune disorder. Physicians should be aware of this adverse reaction by mRNA COVID-19 vaccination and should consider the benefits and risks of vaccination for each recipient. Springer Singapore 2021-10-23 2022 /pmc/articles/PMC8536917/ /pubmed/34687421 http://dx.doi.org/10.1007/s12185-021-03243-2 Text en © Japanese Society of Hematology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Hidaka, Daisuke
Ogasawara, Reiki
Sugimura, Shunsuke
Fujii, Fumiaki
Kojima, Keisuke
Nagai, Jun
Ebata, Ko
Okada, Kohei
Kobayashi, Naoki
Ogasawara, Masahiro
Imamura, Masahiro
Ota, Shuichi
New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
title New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
title_full New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
title_fullStr New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
title_full_unstemmed New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
title_short New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
title_sort new-onset evans syndrome associated with systemic lupus erythematosus after bnt162b2 mrna covid-19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536917/
https://www.ncbi.nlm.nih.gov/pubmed/34687421
http://dx.doi.org/10.1007/s12185-021-03243-2
work_keys_str_mv AT hidakadaisuke newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT ogasawarareiki newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT sugimurashunsuke newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT fujiifumiaki newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT kojimakeisuke newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT nagaijun newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT ebatako newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT okadakohei newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT kobayashinaoki newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT ogasawaramasahiro newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT imamuramasahiro newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination
AT otashuichi newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination